Cannabis

Cannabis Law360 provides breaking news and analysis of emerging and evolving legal issues surrounding cannabis. Coverage ranges from regulatory and policy concerns facing the industry to the business of lawyers who counsel cannabis companies. Among the practice areas covered are intellectual property, mergers & acquisitions and employment.



Sign up for a 7-day FREE trial today!



Latest News in Cannabis

  • June 02, 2026

    8th Circ. Backs Rap Lyrics As Evidence In Drug Convictions

    Lyrics and a music video were properly admitted as evidence against two rappers accused of being a part of a Kansas City, Missouri, drug trafficking ring, the Eighth Circuit has ruled, saying the relevance of the lyrics was "obvious" when affirming their convictions and prison sentences.

  • June 02, 2026

    Lawmakers Seek IRS Tax Guidance For Cannabis Businesses

    A group of seven House Democrats is pressing the Internal Revenue Service and the U.S. Department of the Treasury to issue tax guidance for state-licensed medical cannabis businesses, warning that delay could leave taxpayers unable to claim deductions they might be eligible for after the Trump administration loosened federal restrictions.

  • June 02, 2026

    Panel Unsure Lowenstein Missed Deadline In Pot Biz Fee Row

    A New Jersey appellate panel on Tuesday questioned if Lowenstein Sandler LLP ever filed the amended complaint that would trigger the allegedly missed deadline that Trif & Modugno LLC says is fatal to Lowenstein Sandler's bid for $750,000 in unpaid fees from a failed cannabis venture.

  • June 02, 2026

    LA Says DOJ's Pot Shift Can't Sway Dormant Commerce Case

    Los Angeles urged the Ninth Circuit on Monday to dispose of a dormant commerce clause challenge to the city's cannabis licensure program, saying the federal rescheduling of medical marijuana should not influence the case.

  • June 02, 2026

    Hemp Cos. Say DEA Overreached By Criminalizing HHC

    Two hemp companies are challenging a recent U.S. Drug Enforcement Administration rule that designated a hemp-derived psychoactive compound as a Schedule I substance, saying the agency's move was an unlawful overreach that contradicts Congress' legalization of hemp.

See more Cannabis news

Cannabis

Areas of Coverage

  • AGENCIES
  • U.S. Food & Drug Administration
  • Federal Trade Commission
  • Drug Enforcement Agency
  • U.S. Department of the Treasury
  • California Bureau of Cannabis Control
  • Department of Health & Human Services
  • Financial Crimes Enforcement Network
  • U.S. Securities and Exchange Commission
  • U.S. Commodity Futures Trading Commission
  • U.S. Department of Justice
  • State and international regulators
  • POLICY & REGULATION
  • SAFE Banking Act
  • STATES Act
  • Marijuana Opportunity Reinvestment and Expungement, or MORE, Act
  • Section 280E of the Internal Revenue Code
  • Rohrabacher–Farr amendment
  • Bank Secrecy Act
  • Federal and state legislation
  • ENFORCEMENT
  • FDA and FTC actions over cannabis’s purported health claims
  • IRS actions against cannabis companies
  • Antitrust investigations
  • Financial regulatory actions
  • Federal criminal matters
  • State enforcement actions
  • LITIGATION
  • Civil RICO actions brought against cannabis concerns
  • Employment disputes
  • Securities class actions
  • Intellectual property matters
  • Consumer class actions
  • Bankruptcy
  • Tax disputes
  • Challenges to federal or state regulations
  • TRANSACTIONS
  • M&A activity involving cannabis companies
  • Commercial real estate transactions
  • PROFILES
  • Personnel moves
  • Profiles of law firm cannabis practices
  • Federal and state policymakers and lawmakers
  • General counsel interviews

READERSHIP

  • Cannabis lawyers at large to medium-sized law firms and boutiques
  • In-house counsel, compliance officers and executives at cannabis companies
  • Counsel and executives at venture capital and investment firms
  • Policymakers at federal and state agencies
  • Federal and state lawmakers
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.